Articles related to INSURANCE

As physicians, understanding the new biomarker legislation is crucial—it not only shapes insurance coverage but also influences clinical decision-making and patient access to precision medicine, potentially leading to more cost-effective and targeted care.

Stay abreast of the latest HCPCS updates crucial for oncology practice, including new codes for advanced cancer treatments and essential guidelines for principal illness navigation services, to ensure compliance and optimize reimbursement.

In an era where specialty drug costs soar, Alternative Funding Programs present a complex solution, balancing cost containment with patient access to essential medications. These programs, while offering potential savings, may also introduce treatment delays and increased financial burdens for patients.

The ACA’s preventive care mandate, currently under constitutional review, has significantly impacted rates of cancer screenings and early-stage diagnoses. The outcome of this case could reshape the landscape of preventive care in oncology.

The proposed changes to the 2024 MPFS could have far-reaching implications for oncology care; stay informed to understand how these changes may impact your practice and patient outcomes.

Discover how a recent class-action lawsuit against Bristol Myers Squibb could impact the availability and cost of multiple myeloma treatment options.